Trends in VTE Anticoagulation in Hospitalized COVID-19 Patients – American College of Cardiology
Debabrata Mukherjee, MD, FACC
Related Articles
Advocacy at the ACC – American College of Cardiology
The ACC is leading the transformation of care by advocating for a quality driven health care system, provider stability, population health and the future of…
FDA Update: Heartmate II and Heartmate 3 LVAS Recalled Due to Obstruction – American College of Cardiology
The U.S. Food and Drug Administration (FDA) announced on April 15 that Abbott/Thoratec Corp. is recalling the Heartmate II and Heartmate 3 Left Ventricular Assist…
Realizing Our Vision: ACC’s Next 5-Year Strategic Plan
∗Address for correspondence: Ms Cathleen Biga, American Coll ege of Cardiology, 2400 N Street, NW, Washington, DC 20037, USA. E-mail: E-mail Address: [email protected] As…
ACC President Series | Heart-to-Heart – American College of Cardiology
Join ACC President B. Hadley Wilson, MD, FACC (@HadleyWilsonMD), for his new Heart-to-Heart presidential chat series focused on ACC members and their inspiring work to…
Lp(a) and CV Risk Reduction With Icosapent Ethyl – American College of Cardiology
Elizabeth A. Jackson, MD, FACC
Catheter-Based Therapy for High- or Intermediate-Risk PE – American College of Cardiology
Debabrata Mukherjee, MD, FACC
ACC Middle East 2024 – American College of Cardiology
United by our shared commitment of transforming cardiovascular care, the American College of Cardiology (ACC) and the Egyptian Society of Cardiology invite you to join…
The Future of Cardiology – Value-Based Care, Private Equity and the Practice Landscape – American College of Cardiology
It’s becoming increasingly evident that alongside top-notch clinical expertise, the CV specialist of the future must be surrounded by a multi-talented, diverse team to provide…